VOYA Investment Management’s Cabaletta Bio CABA Stock Holding History

VOYA Investment Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,981	Closed	-$18K	–	2663
2025 Q1	$18K	Sell	12,981 -1,221	-9%	-$2.6K	﹤0.01%	2627
2024 Q4	$32.2K	Sell	14,202 -702	-5%	-$2.46K	﹤0.01%	2719
2024 Q3	$70.3K	Buy	14,904 +611	+4%	+$3.54K	﹤0.01%	2727
2024 Q2	$107K	Sell	14,293 -45,205	-76%	-$554K	﹤0.01%	2649
2024 Q1	$1.02M	Buy	59,498 +45,569	+327%	+$978K	﹤0.01%	1626
2023 Q4	$316K	Hold	13,929	–	–	﹤0.01%	2318
2023 Q3	$212K	Buy	13,929 +3,720	+36%	+$50.8K	﹤0.01%	2509
2023 Q2	$132K	Buy	+10,209	New	+$111K	﹤0.01%	2710

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

VOYA Investment Management's CABA Position: Q2 2025 in Review

VOYA Investment Management sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 12,981 shares — an estimated $18K sold.

VOYA Investment Management first reported a position in CABA in Q2 2023 and held it in 8 quarters. The position peaked at $1.02M in Q1 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

VOYA Investment Management reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
VOYA Investment Management sold 12,981 Cabaletta Bio shares in Q2 2025, an estimated $18K.
VOYA Investment Management first reported a position in Cabaletta Bio in Q2 2023 and held it in 8 quarters.
VOYA Investment Management's Cabaletta Bio position peaked at $1.02M in Q1 2024.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.